TY - JOUR
T1 - Shared genetic risk between eating disorder- and substance-use-related phenotypes
T2 - Evidence from genome-wide association studies
AU - Eating Disorders Working Group of the Psychiatric Genomics Consortium
AU - Munn-Chernoff, Melissa A
AU - Johnson, Emma C
AU - Chou, Yi-Ling
AU - Coleman, Jonathan R I
AU - Thornton, Laura M
AU - Walters, Raymond K
AU - Yilmaz, Zeynep
AU - Baker, Jessica H
AU - Hübel, Christopher
AU - Gordon, Scott
AU - Medland, Sarah E
AU - Watson, Hunna J
AU - Gaspar, Héléna A
AU - Bryois, Julien
AU - Hinney, Anke
AU - Leppä, Virpi M
AU - Mattheisen, Manuel
AU - Ripke, Stephan
AU - Yao, Shuyang
AU - Giusti-Rodríguez, Paola
AU - Hanscombe, Ken B
AU - Adan, Roger A H
AU - Alfredsson, Lars
AU - Ando, Tetsuya
AU - Andreassen, Ole A
AU - Berrettini, Wade H
AU - Boehm, Ilka
AU - Boni, Claudette
AU - Boraska Perica, Vesna
AU - Buehren, Katharina
AU - Burghardt, Roland
AU - Cassina, Matteo
AU - Cichon, Sven
AU - Clementi, Maurizio
AU - Cone, Roger D
AU - Courtet, Philippe
AU - Crow, Scott
AU - Crowley, James J
AU - Danner, Unna N
AU - Davis, Oliver S P
AU - de Zwaan, Martina
AU - Walton, Esther
AU - Zeggini, Eleftheria
AU - Bergen, Andrew W
AU - Parker, Richard
AU - Chen, Li-Shiun
AU - Zhou, Hang
AU - Degenhardt, Louisa
AU - Neale, Benjamin M
N1 - © 2020 Society for the Study of Addiction.
PY - 2020/2/16
Y1 - 2020/2/16
N2 - Eating disorders and substance use disorders frequently co-occur. Twin studies reveal shared genetic variance between liabilities to eating disorders and substance use, with the strongest associations between symptoms of bulimia nervosa and problem alcohol use (genetic correlation [rg ], twin-based = 0.23-0.53). We estimated the genetic correlation between eating disorder and substance use and disorder phenotypes using data from genome-wide association studies (GWAS). Four eating disorder phenotypes (anorexia nervosa [AN], AN with binge eating, AN without binge eating, and a bulimia nervosa factor score), and eight substance-use-related phenotypes (drinks per week, alcohol use disorder [AUD], smoking initiation, current smoking, cigarettes per day, nicotine dependence, cannabis initiation, and cannabis use disorder) from eight studies were included. Significant genetic correlations were adjusted for variants associated with major depressive disorder and schizophrenia. Total study sample sizes per phenotype ranged from ~2400 to ~537 000 individuals. We used linkage disequilibrium score regression to calculate single nucleotide polymorphism-based genetic correlations between eating disorder- and substance-use-related phenotypes. Significant positive genetic associations emerged between AUD and AN (rg = 0.18; false discovery rate q = 0.0006), cannabis initiation and AN (rg = 0.23; q < 0.0001), and cannabis initiation and AN with binge eating (rg = 0.27; q = 0.0016). Conversely, significant negative genetic correlations were observed between three nondiagnostic smoking phenotypes (smoking initiation, current smoking, and cigarettes per day) and AN without binge eating (rgs = -0.19 to -0.23; qs < 0.04). The genetic correlation between AUD and AN was no longer significant after co-varying for major depressive disorder loci. The patterns of association between eating disorder- and substance-use-related phenotypes highlights the potentially complex and substance-specific relationships among these behaviors.
AB - Eating disorders and substance use disorders frequently co-occur. Twin studies reveal shared genetic variance between liabilities to eating disorders and substance use, with the strongest associations between symptoms of bulimia nervosa and problem alcohol use (genetic correlation [rg ], twin-based = 0.23-0.53). We estimated the genetic correlation between eating disorder and substance use and disorder phenotypes using data from genome-wide association studies (GWAS). Four eating disorder phenotypes (anorexia nervosa [AN], AN with binge eating, AN without binge eating, and a bulimia nervosa factor score), and eight substance-use-related phenotypes (drinks per week, alcohol use disorder [AUD], smoking initiation, current smoking, cigarettes per day, nicotine dependence, cannabis initiation, and cannabis use disorder) from eight studies were included. Significant genetic correlations were adjusted for variants associated with major depressive disorder and schizophrenia. Total study sample sizes per phenotype ranged from ~2400 to ~537 000 individuals. We used linkage disequilibrium score regression to calculate single nucleotide polymorphism-based genetic correlations between eating disorder- and substance-use-related phenotypes. Significant positive genetic associations emerged between AUD and AN (rg = 0.18; false discovery rate q = 0.0006), cannabis initiation and AN (rg = 0.23; q < 0.0001), and cannabis initiation and AN with binge eating (rg = 0.27; q = 0.0016). Conversely, significant negative genetic correlations were observed between three nondiagnostic smoking phenotypes (smoking initiation, current smoking, and cigarettes per day) and AN without binge eating (rgs = -0.19 to -0.23; qs < 0.04). The genetic correlation between AUD and AN was no longer significant after co-varying for major depressive disorder loci. The patterns of association between eating disorder- and substance-use-related phenotypes highlights the potentially complex and substance-specific relationships among these behaviors.
U2 - 10.1111/adb.12880
DO - 10.1111/adb.12880
M3 - Article (Academic Journal)
C2 - 32064741
SN - 1355-6215
SP - e12880
JO - Addiction Biology
JF - Addiction Biology
ER -